Retinoblastoma in children, experience at a pediatric hospital
PDF (Español (España))

Keywords

Retinoblastoma
Treatment
Chemotherapy
Ophthalmology
Oncology

How to Cite

1.
Trincado M. A, López G. JP, González N. M, Villaseca D. E, Roizen B. A, Manieu M. D, Díaz C. J, Villarroel C. M, Henríquez V. A, Latorre L. JJ, Galano Triviño S. Retinoblastoma in children, experience at a pediatric hospital. Andes pediatr [Internet]. 2008 Jul. 20 [cited 2026 Apr. 15];79(6):614-22. Available from: https://andespediatrica.cl/index.php/rchped/article/view/2522

Abstract

Methods: Retrospective analysis of clinical charts of 41 children (59 eyes) diagnosed with retinoblastoma and treated by a multidisciplinary team at Hospital Luis Calvo Mackenna in Santiago-Chile, between 1999 and 2007. The information included gender, laterality, diagnosis age, presenting signs, tumor spread, treatment modality and survival rate. 

Results: A total of 23 cases (56%) were unilateral and 18 cases (44%) were bilateral. The mean age at diagnosis was 21.6 months (range 2 - 84) and 27 children (65.9%) were male. The most common presenting signs were leucokoria (51.2%), strabismus (24.4%) and proptosis (4.9%). Enucleation was performed in 48 eyes (81.3%), being the only required treatment in 17 children (41.5%). The remaining 24 patients received systemic and/or local therapy with chemotherapy, focal therapy and external beam radiation. 5 children died during the follow - up study period, due to extraocular extensión to the orbit, central nervous system and bone marrow. 

Conclusión: In spite of high enucleation rate as initial therapy for retinoblastoma, the survival rate with this current treatment protocol is similar to those from developed countries.


PDF (Español (España))

Los contenidos publicados en esta revista están protegidos bajo una Licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0). Esto significa que cualquier persona es libre de compartir,  usar y construir a partir de este artículo, incluso con fines comerciales, siempre que se otorgue el crédito apropiado al autor original, se proporcione un enlace a la licencia, se indique el nombre y edición de la Revista.

Esta licencia no impone restricciones adicionales, lo que garantiza la libre circulación y reutilización del conocimiento con respeto y transparencia hacia los derechos de los autores.  (Véase El efecto del acceso abierto).